Biomarkers

SMi Group is proud to announce their 4th annual Biomarkers Summit...
Biomarkers Summit
Biomarker Discovery, Validation and Qualification
31st January to 1st February 2011, Crowne Plaza - The City, London, United Kingdom.
Sponsored by RBM

Overview
It is now clear that the use of biomarkers is an integral part in the future of medicine. With rising development costs and a declining rate of new drug discovery, pharmaceutical companies are now incorporating biomarker strategies into all new R&D processes.
With the industry currently realising the benefits to be had from joint R&D projects and key collaborations, it is now estimated that the Biomarker market value will reach over $12.8 Billion dollars by 2012.
Likewise the level of innovation in Biomarker applications and translational science is seeing increasingly rapid growth. With new discoveries being made in every therapeutic category, Biomarkers are promising to drive forward new drug discovery, companion diagnostics, and to wholly improve patient outcomes.

Please note this is a two track event on the first day and single track on the second, followed by an opt in workshop on the third morning.

Conference highlights include
• Two distinct presentation streams covering Oncology, and also Immunology & CNS
• 27 expert speakers providing key insights into current Biomarker R&D
• New developments in Biomarker Discovery, Validation, and Qualification
• Stratification Biomarkers in Personalised Medicine
• Pharmacology Biomarkers and PK/PD modelling
• The application of informatics to Biomarker development

Why not attend the associated workshop as well?
Associated with the conference there will be a half-day workshop on "Fit for Purpose Biomarkers: From Bench to Bedside", taking place on the 2nd February.

This highly interactive workshop will highlight the nature and requirements of the different classes of biomarkers, the technologies most suited to developing biomarkers, and discuss case studies of biomarker development and implementation which will help illuminate the key issues which can arrive during the journey from bench to bedside.

This will be led by Eric Culbert, the Executive Director of BioScience Innovations Ltd. To see more information about the workshop, please see the workshop page.

URL: www.smi-online.co.uk/preclinical-biomarkers36.asp
Contact Name: Zain Philbey
Contact Number: +44 (0) 20 7827 6722
Contact email: zphilbey@smi-online.co.uk

SMi have had an established portfolio of Pharmaceutical, Defence, Energy, Finance and PPP/PFI events running since 1993. We are at the forefront of linking businesses with information, organising over 150 Conferences, Workshops and Masterclasses every year. All our events are research driven and highly targeted towards senior level professionals, designed to help you make informed decisions and remain at the cutting edge of business information.

SMi Conferences offer you an unrivalled opportunity to network within your area of business and our Workshops and Masterclasses provide an intimate, interactive forum in which to learn about the latest techniques and developments.

SMi Group Ltd,
Unit 122, Great Guildford Business Square,
30 Great Guildford Street,
London, SE1 0HS,
United Kingdom.

Contact Name: Zain Philbey
Contact Number: +44 (0) 20 7827 6722
Contact email: zphilbey@smi-online.co.uk

This release was published on openPR.